25 XP   0   0   10

Jacobio Pharmaceuticals Group Co Lt
Buy, Hold or Sell?

Let's analyse Jacobio Pharmaceuticals Group Co Lt together

PenkeI guess you are interested in Jacobio Pharmaceuticals Group Co Lt. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jacobio Pharmaceuticals Group Co Lt. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jacobio Pharmaceuticals Group Co Lt

I send you an email if I find something interesting about Jacobio Pharmaceuticals Group Co Lt.

Quick analysis of Jacobio Pharmaceuticals Group Co Lt (30 sec.)










What can you expect buying and holding a share of Jacobio Pharmaceuticals Group Co Lt? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
HK$1.62
Expected worth in 1 year
HK$-0.17
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
HK$-1.79
Return On Investment
-117.8%

For what price can you sell your share?

Current Price per Share
HK$1.52
Expected price per share
HK$0 - HK$1.8
How sure are you?
50%

1. Valuation of Jacobio Pharmaceuticals Group Co Lt (5 min.)




Live pricePrice per Share (EOD)

HK$1.52

Intrinsic Value Per Share

HK$-4.58 - HK$-5.48

Total Value Per Share

HK$-2.96 - HK$-3.86

2. Growth of Jacobio Pharmaceuticals Group Co Lt (5 min.)




Is Jacobio Pharmaceuticals Group Co Lt growing?

Current yearPrevious yearGrowGrow %
How rich?$163.7m$209m-$45.2m-27.6%

How much money is Jacobio Pharmaceuticals Group Co Lt making?

Current yearPrevious yearGrowGrow %
Making money-$47.4m-$38.4m-$9m-19.0%
Net Profit Margin-388.4%-197.1%--

How much money comes from the company's main activities?

3. Financial Health of Jacobio Pharmaceuticals Group Co Lt (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#283 / 1010

Most Revenue
#281 / 1010

Most Profit
#884 / 1010

Most Efficient
#707 / 1010

What can you expect buying and holding a share of Jacobio Pharmaceuticals Group Co Lt? (5 min.)

Welcome investor! Jacobio Pharmaceuticals Group Co Lt's management wants to use your money to grow the business. In return you get a share of Jacobio Pharmaceuticals Group Co Lt.

What can you expect buying and holding a share of Jacobio Pharmaceuticals Group Co Lt?

First you should know what it really means to hold a share of Jacobio Pharmaceuticals Group Co Lt. And how you can make/lose money.

Speculation

The Price per Share of Jacobio Pharmaceuticals Group Co Lt is HK$1.52. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jacobio Pharmaceuticals Group Co Lt.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jacobio Pharmaceuticals Group Co Lt, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$1.62. Based on the TTM, the Book Value Change Per Share is HK$-0.45 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jacobio Pharmaceuticals Group Co Lt.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.06-3.9%-0.06-3.9%-0.05-3.2%-0.09-5.9%-0.09-5.9%
Usd Book Value Change Per Share-0.06-3.8%-0.06-3.8%-0.02-1.6%0.042.7%0.042.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-3.8%-0.06-3.8%-0.02-1.6%0.042.8%0.042.8%
Usd Price Per Share0.67-0.67-1.85-0.87-0.87-
Price to Earnings Ratio-11.14--11.14--38.12--11.33--11.33-
Price-to-Total Gains Ratio-11.68--11.68--76.99--27.90--27.90-
Price to Book Ratio3.23-3.23-7.01-3.30-3.30-
Price-to-Total Gains Ratio-11.68--11.68--76.99--27.90--27.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.194104
Number of shares5151
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.04
Usd Total Gains Per Share-0.060.04
Gains per Quarter (5151 shares)-294.57216.16
Gains per Year (5151 shares)-1,178.27864.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1178-118812852855
20-2357-23662417051720
30-3535-35443725572585
40-4713-47224934103450
50-5891-59006142624315
60-7070-70787351145180
70-8248-82568659676045
80-9426-94349868196910
90-10604-1061211076727775
100-11783-1179012285248640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.04.00.020.0%1.04.00.020.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.04.020.0%1.00.04.020.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.04.00.020.0%1.04.00.020.0%

Fundamentals of Jacobio Pharmaceuticals Group Co Lt

About Jacobio Pharmaceuticals Group Co Lt

Jacobio Pharmaceuticals Group Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-(L)1 resistant cancer; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, a tumor metabolic pathway for the treatment of solid tumors; and JAB-BX300, a molecule antibody targeting RAS pathway to treat pancreatic and other solid tumors with KRAS mutations. The company has a strategic collaboration with AbbVie Ireland Unlimited Company to develop and commercialize SHP2 inhibitors. The company was founded in 2015 and is headquartered in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-16 09:04:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jacobio Pharmaceuticals Group Co Lt.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jacobio Pharmaceuticals Group Co Lt earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Jacobio Pharmaceuticals Group Co Lt to the Biotechnology industry mean.
  • A Net Profit Margin of -388.4% means that $-3.88 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is -388.4%. The company is making a huge loss. -2
  • The TTM is -388.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-388.4%TTM-388.4%0.0%
TTM-388.4%YOY-197.1%-191.3%
TTM-388.4%5Y-179.4%-209.0%
5Y-179.4%10Y-179.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-388.4%-200.1%-188.3%
TTM-388.4%-216.8%-171.6%
YOY-197.1%-288.3%+91.2%
5Y-179.4%-449.1%+269.7%
10Y-179.4%-605.5%+426.1%
1.1.2. Return on Assets

Shows how efficient Jacobio Pharmaceuticals Group Co Lt is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jacobio Pharmaceuticals Group Co Lt to the Biotechnology industry mean.
  • -23.6% Return on Assets means that Jacobio Pharmaceuticals Group Co Lt generated $-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is -23.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.6%TTM-23.6%0.0%
TTM-23.6%YOY-17.5%-6.1%
TTM-23.6%5Y-54.1%+30.5%
5Y-54.1%10Y-54.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.6%-13.3%-10.3%
TTM-23.6%-12.8%-10.8%
YOY-17.5%-11.7%-5.8%
5Y-54.1%-13.9%-40.2%
10Y-54.1%-15.7%-38.4%
1.1.3. Return on Equity

Shows how efficient Jacobio Pharmaceuticals Group Co Lt is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jacobio Pharmaceuticals Group Co Lt to the Biotechnology industry mean.
  • -29.0% Return on Equity means Jacobio Pharmaceuticals Group Co Lt generated $-0.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is -29.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.0%TTM-29.0%0.0%
TTM-29.0%YOY-18.4%-10.6%
TTM-29.0%5Y-26.4%-2.6%
5Y-26.4%10Y-26.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.0%-16.9%-12.1%
TTM-29.0%-16.1%-12.9%
YOY-18.4%-15.1%-3.3%
5Y-26.4%-19.3%-7.1%
10Y-26.4%-20.2%-6.2%

1.2. Operating Efficiency of Jacobio Pharmaceuticals Group Co Lt.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jacobio Pharmaceuticals Group Co Lt is operating .

  • Measures how much profit Jacobio Pharmaceuticals Group Co Lt makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jacobio Pharmaceuticals Group Co Lt to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-191.3%+191.3%
TTM-5Y-29.6%+29.6%
5Y-29.6%10Y-29.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY-191.3%-298.2%+106.9%
5Y-29.6%-492.1%+462.5%
10Y-29.6%-632.4%+602.8%
1.2.2. Operating Ratio

Measures how efficient Jacobio Pharmaceuticals Group Co Lt is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 6.83 means that the operating costs are $6.83 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is 6.826. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.826. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.826TTM6.8260.000
TTM6.826YOY3.894+2.932
TTM6.8265Y2.276+4.550
5Y2.27610Y2.2760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8263.231+3.595
TTM6.8263.310+3.516
YOY3.8943.890+0.004
5Y2.2765.739-3.463
10Y2.2767.876-5.600

1.3. Liquidity of Jacobio Pharmaceuticals Group Co Lt.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jacobio Pharmaceuticals Group Co Lt is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.59 means the company has $8.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is 8.590. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.590. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.590TTM8.5900.000
TTM8.590YOY20.285-11.695
TTM8.5905Y16.813-8.223
5Y16.81310Y16.8130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5903.890+4.700
TTM8.5904.173+4.417
YOY20.2855.344+14.941
5Y16.8136.126+10.687
10Y16.8136.448+10.365
1.3.2. Quick Ratio

Measures if Jacobio Pharmaceuticals Group Co Lt is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jacobio Pharmaceuticals Group Co Lt to the Biotechnology industry mean.
  • A Quick Ratio of 8.43 means the company can pay off $8.43 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is 8.429. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.429. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.429TTM8.4290.000
TTM8.429YOY20.229-11.800
TTM8.4295Y16.767-8.338
5Y16.76710Y16.7670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4293.514+4.915
TTM8.4293.998+4.431
YOY20.2295.380+14.849
5Y16.7676.105+10.662
10Y16.7676.404+10.363

1.4. Solvency of Jacobio Pharmaceuticals Group Co Lt.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jacobio Pharmaceuticals Group Co Lt assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jacobio Pharmaceuticals Group Co Lt to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Jacobio Pharmaceuticals Group Co Lt assets are financed with 18.6% credit (debt) and the remaining percentage (100% - 18.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is 0.186. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.186. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.186TTM0.1860.000
TTM0.186YOY0.049+0.136
TTM0.1865Y0.755-0.570
5Y0.75510Y0.7550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1860.339-0.153
TTM0.1860.336-0.150
YOY0.0490.271-0.222
5Y0.7550.366+0.389
10Y0.7550.389+0.366
1.4.2. Debt to Equity Ratio

Measures if Jacobio Pharmaceuticals Group Co Lt is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jacobio Pharmaceuticals Group Co Lt to the Biotechnology industry mean.
  • A Debt to Equity ratio of 22.8% means that company has $0.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The MRQ is 0.228. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.228. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.228TTM0.2280.000
TTM0.228YOY0.052+0.176
TTM0.2285Y0.065+0.163
5Y0.06510Y0.0650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2280.388-0.160
TTM0.2280.402-0.174
YOY0.0520.335-0.283
5Y0.0650.426-0.361
10Y0.0650.461-0.396

2. Market Valuation of Jacobio Pharmaceuticals Group Co Lt

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Jacobio Pharmaceuticals Group Co Lt generates.

  • Above 15 is considered overpriced but always compare Jacobio Pharmaceuticals Group Co Lt to the Biotechnology industry mean.
  • A PE ratio of -11.14 means the investor is paying $-11.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The EOD is -3.236. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.136. Based on the earnings, the company is expensive. -2
  • The TTM is -11.136. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.236MRQ-11.136+7.899
MRQ-11.136TTM-11.1360.000
TTM-11.136YOY-38.117+26.982
TTM-11.1365Y-11.332+0.196
5Y-11.33210Y-11.3320.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.236-2.264-0.972
MRQ-11.136-2.629-8.507
TTM-11.136-2.680-8.456
YOY-38.117-4.145-33.972
5Y-11.332-6.257-5.075
10Y-11.332-6.254-5.078
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The EOD is -3.606. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.407. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.407. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.606MRQ-12.407+8.801
MRQ-12.407TTM-12.4070.000
TTM-12.407YOY-66.988+54.581
TTM-12.4075Y14.701-27.108
5Y14.70110Y14.7010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.606-2.973-0.633
MRQ-12.407-3.333-9.074
TTM-12.407-3.553-8.854
YOY-66.988-5.605-61.383
5Y14.701-8.376+23.077
10Y14.701-8.865+23.566
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jacobio Pharmaceuticals Group Co Lt is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.23 means the investor is paying $3.23 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Jacobio Pharmaceuticals Group Co Lt:

  • The EOD is 0.938. Based on the equity, the company is cheap. +2
  • The MRQ is 3.229. Based on the equity, the company is fair priced.
  • The TTM is 3.229. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD0.938MRQ3.229-2.290
MRQ3.229TTM3.2290.000
TTM3.229YOY7.013-3.784
TTM3.2295Y3.304-0.075
5Y3.30410Y3.3040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9381.896-0.958
MRQ3.2292.115+1.114
TTM3.2292.093+1.136
YOY7.0132.884+4.129
5Y3.3043.542-0.238
10Y3.3043.916-0.612
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jacobio Pharmaceuticals Group Co Lt compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.448-0.4480%-0.188-58%0.324-238%0.324-238%
Book Value Per Share--1.6201.6200%2.068-22%1.045+55%1.045+55%
Current Ratio--8.5908.5900%20.285-58%16.813-49%16.813-49%
Debt To Asset Ratio--0.1860.1860%0.049+277%0.755-75%0.755-75%
Debt To Equity Ratio--0.2280.2280%0.052+340%0.065+250%0.065+250%
Dividend Per Share----0%-0%0.005-100%0.005-100%
Eps---0.470-0.4700%-0.380-19%-0.697+48%-0.697+48%
Free Cash Flow Per Share---0.422-0.4220%-0.216-49%-0.167-60%-0.167-60%
Free Cash Flow To Equity Per Share---0.435-0.4350%-0.068-84%0.306-242%0.306-242%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.478--------
Intrinsic Value_10Y_min---4.575--------
Intrinsic Value_1Y_max---0.262--------
Intrinsic Value_1Y_min---0.254--------
Intrinsic Value_3Y_max---1.005--------
Intrinsic Value_3Y_min---0.945--------
Intrinsic Value_5Y_max---2.012--------
Intrinsic Value_5Y_min---1.830--------
Market Cap1203467612.160-244%4140878691.8404140878691.8400%11480447616.000-64%5366515444.224-23%5366515444.224-23%
Net Profit Margin---3.884-3.8840%-1.971-49%-1.794-54%-1.794-54%
Operating Margin----0%-1.9130%-0.2960%-0.2960%
Operating Ratio--6.8266.8260%3.894+75%2.276+200%2.276+200%
Pb Ratio0.938-244%3.2293.2290%7.013-54%3.304-2%3.304-2%
Pe Ratio-3.236+71%-11.136-11.1360%-38.117+242%-11.332+2%-11.332+2%
Price Per Share1.520-244%5.2305.2300%14.500-64%6.778-23%6.778-23%
Price To Free Cash Flow Ratio-3.606+71%-12.407-12.4070%-66.988+440%14.701-184%14.701-184%
Price To Total Gains Ratio-3.394+71%-11.679-11.6790%-76.992+559%-27.901+139%-27.901+139%
Quick Ratio--8.4298.4290%20.229-58%16.767-50%16.767-50%
Return On Assets---0.236-0.2360%-0.175-26%-0.541+129%-0.541+129%
Return On Equity---0.290-0.2900%-0.184-37%-0.264-9%-0.264-9%
Total Gains Per Share---0.448-0.4480%-0.188-58%0.329-236%0.329-236%
Usd Book Value--163778314.800163778314.8000%209056137.600-22%105697009.060+55%105697009.060+55%
Usd Book Value Change Per Share---0.057-0.0570%-0.024-58%0.041-238%0.041-238%
Usd Book Value Per Share--0.2070.2070%0.264-22%0.133+55%0.133+55%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.060-0.0600%-0.049-19%-0.089+48%-0.089+48%
Usd Free Cash Flow---42621342.222-42621342.2220%-21885303.999-49%-16887805.241-60%-16887805.241-60%
Usd Free Cash Flow Per Share---0.054-0.0540%-0.028-49%-0.021-60%-0.021-60%
Usd Free Cash Flow To Equity Per Share---0.056-0.0560%-0.009-84%0.039-242%0.039-242%
Usd Market Cap153682814.073-244%528790208.948528790208.9480%1466053160.563-64%685304022.227-23%685304022.227-23%
Usd Price Per Share0.194-244%0.6680.6680%1.852-64%0.866-23%0.866-23%
Usd Profit---47486649.700-47486649.7000%-38461579.900-19%-70508942.040+48%-70508942.040+48%
Usd Revenue--12226764.20012226764.2000%19513709.300-37%18767839.140-35%18767839.140-35%
Usd Total Gains Per Share---0.057-0.0570%-0.024-58%0.042-236%0.042-236%
 EOD+3 -5MRQTTM+0 -0YOY+3 -295Y+12 -2210Y+12 -22

3.2. Fundamental Score

Let's check the fundamental score of Jacobio Pharmaceuticals Group Co Lt based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.236
Price to Book Ratio (EOD)Between0-10.938
Net Profit Margin (MRQ)Greater than0-3.884
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.429
Current Ratio (MRQ)Greater than18.590
Debt to Asset Ratio (MRQ)Less than10.186
Debt to Equity Ratio (MRQ)Less than10.228
Return on Equity (MRQ)Greater than0.15-0.290
Return on Assets (MRQ)Greater than0.05-0.236
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Jacobio Pharmaceuticals Group Co Lt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.024
Ma 20Greater thanMa 501.601
Ma 50Greater thanMa 1001.959
Ma 100Greater thanMa 2002.644
OpenGreater thanClose1.420
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Retained Earnings  -211,306-424,811-636,117-1,525,515-2,161,632-301,187-2,462,8193,744,6701,281,851



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets1,574,647
Total Liabilities292,123
Total Stockholder Equity1,282,524
 As reported
Total Liabilities 292,123
Total Stockholder Equity+ 1,282,524
Total Assets = 1,574,647

Assets

Total Assets1,574,647
Total Current Assets1,338,747
Long-term Assets235,900
Total Current Assets
Cash And Cash Equivalents 1,298,688
Net Receivables 15,033
Total Current Assets  (as reported)1,338,747
Total Current Assets  (calculated)1,313,721
+/- 25,026
Long-term Assets
Property Plant Equipment 205,228
Intangible Assets 1,019
Long-term Assets  (as reported)235,900
Long-term Assets  (calculated)206,247
+/- 29,653

Liabilities & Shareholders' Equity

Total Current Liabilities155,851
Long-term Liabilities136,272
Total Stockholder Equity1,282,524
Total Current Liabilities
Accounts payable 96,551
Total Current Liabilities  (as reported)155,851
Total Current Liabilities  (calculated)96,551
+/- 59,300
Long-term Liabilities
Long term Debt Total 134,663
Long-term Liabilities  (as reported)136,272
Long-term Liabilities  (calculated)134,663
+/- 1,609
Total Stockholder Equity
Common Stock510
Retained Earnings 1,281,851
Other Stockholders Equity 163
Total Stockholder Equity (as reported)1,282,524
Total Stockholder Equity (calculated)1,282,524
+/-0
Other
Capital Stock510
Cash and Short Term Investments 1,298,688
Common Stock Shares Outstanding 771,462
Liabilities and Stockholders Equity 1,574,647
Net Invested Capital 1,282,524
Net Working Capital 1,182,896
Property Plant and Equipment Gross 262,582



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
473,596
363,327
1,867,350
1,721,834
1,574,647
1,574,6471,721,8341,867,350363,327473,596
   > Total Current Assets 
425,031
318,084
1,815,348
1,639,727
1,338,747
1,338,7471,639,7271,815,348318,084425,031
       Cash And Cash Equivalents 
420,833
314,338
1,626,163
1,527,204
1,298,688
1,298,6881,527,2041,626,163314,338420,833
       Net Receivables 
4,198
3,746
187,156
97,594
15,033
15,03397,594187,1563,7464,198
       Other Current Assets 
0
0
784
4,550
0
04,55078400
   > Long-term Assets 
48,565
45,243
52,002
82,107
235,900
235,90082,10752,00245,24348,565
       Property Plant Equipment 
35,287
34,030
34,129
41,772
205,228
205,22841,77234,12934,03035,287
       Intangible Assets 
3,889
0
1,171
1,548
1,019
1,0191,5481,17103,889
       Other Assets 
9,389
11,213
16,702
22,559
0
022,55916,70211,2139,389
> Total Liabilities 
570,841
833,405
81,150
84,746
292,123
292,12384,74681,150833,405570,841
   > Total Current Liabilities 
17,965
45,721
73,878
80,833
155,851
155,85180,83373,87845,72117,965
       Short-term Debt 
0
695
0
0
0
0006950
       Accounts payable 
9,002
12,737
28,281
51,047
96,551
96,55151,04728,28112,7379,002
       Other Current Liabilities 
3,570
3,754
22,373
5,719
0
05,71922,3733,7543,570
   > Long-term Liabilities 
552,876
787,684
7,272
3,913
136,272
136,2723,9137,272787,684552,876
       Long term Debt Total 
544,434
781,072
2,011
1,889
134,663
134,6631,8892,011781,072544,434
       Capital Lease Obligations Min Short Term Debt
15,467
19,831
10,648
6,807
147,794
147,7946,80710,64819,83115,467
> Total Stockholder Equity
-95,365
-469,809
1,786,200
1,637,088
1,282,524
1,282,5241,637,0881,786,200-469,809-95,365
   Common Stock
30
30
502
510
510
5105105023030
   Retained Earnings 
-211,306
-636,117
-2,161,632
-2,462,819
1,281,851
1,281,851-2,462,819-2,161,632-636,117-211,306
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
115,911
166,278
3,947,330
4,099,397
163
1634,099,3973,947,330166,278115,911



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue95,746
Cost of Revenue-83,112
Gross Profit12,63412,634
 
Operating Income (+$)
Gross Profit12,634
Operating Expense-570,480
Operating Income-394,201-557,846
 
Operating Expense (+$)
Research Development445,647
Selling General Administrative41,525
Selling And Marketing Expenses-
Operating Expense570,480487,172
 
Net Interest Income (+$)
Interest Income22,340
Interest Expense-79,509
Other Finance Cost-79,509
Net Interest Income22,340
 
Pretax Income (+$)
Operating Income-394,201
Net Interest Income22,340
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-371,861-394,201
EBIT - interestExpense = -79,509
-371,861
-292,352
Interest Expense79,509
Earnings Before Interest and Taxes (EBIT)--292,352
Earnings Before Interest and Taxes (EBITDA)-355,796
 
After tax Income (+$)
Income Before Tax-371,861
Tax Provision-0
Net Income From Continuing Ops-371,861-371,861
Net Income-371,861
Net Income Applicable To Common Shares-371,861
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--22,340
 

Technical Analysis of Jacobio Pharmaceuticals Group Co Lt
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jacobio Pharmaceuticals Group Co Lt. The general trend of Jacobio Pharmaceuticals Group Co Lt is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jacobio Pharmaceuticals Group Co Lt's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jacobio Pharmaceuticals Group Co Lt.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.5 < 1.55 < 1.8.

The bearish price targets are: .

Tweet this
Jacobio Pharmaceuticals Group Co Lt Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jacobio Pharmaceuticals Group Co Lt. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jacobio Pharmaceuticals Group Co Lt Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jacobio Pharmaceuticals Group Co Lt. The current macd is -0.13652497.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jacobio Pharmaceuticals Group Co Lt price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jacobio Pharmaceuticals Group Co Lt. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jacobio Pharmaceuticals Group Co Lt price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jacobio Pharmaceuticals Group Co Lt Daily Moving Average Convergence/Divergence (MACD) ChartJacobio Pharmaceuticals Group Co Lt Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jacobio Pharmaceuticals Group Co Lt. The current adx is 22.63.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jacobio Pharmaceuticals Group Co Lt shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jacobio Pharmaceuticals Group Co Lt Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jacobio Pharmaceuticals Group Co Lt. The current sar is 1.77877357.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jacobio Pharmaceuticals Group Co Lt Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jacobio Pharmaceuticals Group Co Lt. The current rsi is 38.02. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Jacobio Pharmaceuticals Group Co Lt Daily Relative Strength Index (RSI) ChartJacobio Pharmaceuticals Group Co Lt Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jacobio Pharmaceuticals Group Co Lt. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jacobio Pharmaceuticals Group Co Lt price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jacobio Pharmaceuticals Group Co Lt Daily Stochastic Oscillator ChartJacobio Pharmaceuticals Group Co Lt Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jacobio Pharmaceuticals Group Co Lt. The current cci is -94.96944053.

Jacobio Pharmaceuticals Group Co Lt Daily Commodity Channel Index (CCI) ChartJacobio Pharmaceuticals Group Co Lt Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jacobio Pharmaceuticals Group Co Lt. The current cmo is -19.69140689.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jacobio Pharmaceuticals Group Co Lt Daily Chande Momentum Oscillator (CMO) ChartJacobio Pharmaceuticals Group Co Lt Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jacobio Pharmaceuticals Group Co Lt. The current willr is -66.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jacobio Pharmaceuticals Group Co Lt is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jacobio Pharmaceuticals Group Co Lt Daily Williams %R ChartJacobio Pharmaceuticals Group Co Lt Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jacobio Pharmaceuticals Group Co Lt.

Jacobio Pharmaceuticals Group Co Lt Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jacobio Pharmaceuticals Group Co Lt. The current atr is 0.13321979.

Jacobio Pharmaceuticals Group Co Lt Daily Average True Range (ATR) ChartJacobio Pharmaceuticals Group Co Lt Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jacobio Pharmaceuticals Group Co Lt. The current obv is 149,682,045.

Jacobio Pharmaceuticals Group Co Lt Daily On-Balance Volume (OBV) ChartJacobio Pharmaceuticals Group Co Lt Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jacobio Pharmaceuticals Group Co Lt. The current mfi is 59.88.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jacobio Pharmaceuticals Group Co Lt Daily Money Flow Index (MFI) ChartJacobio Pharmaceuticals Group Co Lt Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jacobio Pharmaceuticals Group Co Lt.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Jacobio Pharmaceuticals Group Co Lt Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jacobio Pharmaceuticals Group Co Lt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.024
Ma 20Greater thanMa 501.601
Ma 50Greater thanMa 1001.959
Ma 100Greater thanMa 2002.644
OpenGreater thanClose1.420
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jacobio Pharmaceuticals Group Co Lt with someone you think should read this too:
  • Are you bullish or bearish on Jacobio Pharmaceuticals Group Co Lt? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jacobio Pharmaceuticals Group Co Lt? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jacobio Pharmaceuticals Group Co Lt

I send you an email if I find something interesting about Jacobio Pharmaceuticals Group Co Lt.


Comments

How you think about this?

Leave a comment

Stay informed about Jacobio Pharmaceuticals Group Co Lt.

Receive notifications about Jacobio Pharmaceuticals Group Co Lt in your mailbox!